WO1992003572A1 - Verfahren zur herstellung von 17-oxosteroiden - Google Patents
Verfahren zur herstellung von 17-oxosteroiden Download PDFInfo
- Publication number
- WO1992003572A1 WO1992003572A1 PCT/DE1991/000628 DE9100628W WO9203572A1 WO 1992003572 A1 WO1992003572 A1 WO 1992003572A1 DE 9100628 W DE9100628 W DE 9100628W WO 9203572 A1 WO9203572 A1 WO 9203572A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- nrrl
- mycobacterium
- oxosteroids
- hydroxysteroids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
- C12P33/12—Acting on D ring
- C12P33/16—Acting at 17 position
Definitions
- the invention relates to a process for the preparation of 17-oxosteroids by fermentative oxidation of 17 ⁇ -hydroxysteroids.
- 17-oxosteroids such as 4-androstene-3,17-dione, 1,4-androstadiene-3,17-dione or 3-hydroxy-1,3,5 (10) -estratrien-17-one
- 17-oxosteroids such as 4-androstene-3,17-dione, 1,4-androstadiene-3,17-dione or 3-hydroxy-1,3,5 (10) -estratrien-17-one
- 17-oxosteroids can be produced in high yields from 17 ⁇ -hydroxysteroids if, for the fermentation of the 17ß-hydroxysteroids, bacterial cultures of the species Mycobacterium spec. NRRL B-3805, Mycobacterium spec. NRRL B-3683, Mycobacterium phlei NRRL B-8154 or Mycobacterium fortuitum NRRL B-8153.
- the process according to the invention is carried out under the same fermentation conditions which are also used in the known microbiological conversions with these bacterial cultures.
- submerged cultures are grown in a suitable nutrient medium with aeration. Then the cultures are added to the substrate (dissolved in a suitable solvent or in emulsified form)
- Suitable substrate solvents are, for example, methanol, ethanol, glycol monomethyl ether, dimethylformamide or dimethyl sulfoxide.
- Emulsification of the substrate can be effected, for example, by using it in micronized form or in a water-miscible form
- Solvents such as methanol, ethanol, acetone, glycol monomethyl ether, dimethylformamide or dimethyl sulfoxide
- emulsification aids are nonionic
- Emulsifiers such as, for example, ethyleneoxy adducts or fatty acid esters of polyglycols.
- the commercially available wetting agents Tegin®, Tween® and Span® may be mentioned as examples of suitable emulsifiers.
- R 1 represents a hydrogen atom or a methyl group
- a lower alkoxy group should preferably be understood to mean a group which has up to 4 carbon atoms. Suitable alkoxy groups are, for example, the methoxy group or the tert-butyloxy group. Under a lower-1-alkoxy-alkoxy group, preferably a meder-alkoxymethoxy group having up to 4 carbon atoms
- Alkoxy group can be understood.
- the 1-methoxymethoxy group may be mentioned as an example.
- a lower alkylenedioxy group should preferably be understood to mean a group having 2 to 6 carbon atoms, such as, for example, the ethylenedioxy group or the 2, 2-dimethylpropylenedioxy group.
- Substrates which are suitable for carrying out the process according to the invention are, for example, estran-17 ⁇ -ol derivatives of the general formula Ia
- R 1 has the meaning given above
- R 2 represents a hydrogen atom or one containing up to 4 carbon atoms
- estran-17-one derivatives formed from these substrates or the 3-hydroxy compounds obtained therefrom by ether cleavage are known to be pharmacologically active and, moreover, are known to be able to be reduced to the corresponding 17 ⁇ -hydroxy compounds or to be converted into the corresponding 17 ⁇ -hydroxy-17 ⁇ -ethynyl compounds.
- Suitable substrates are also tarran derivatives of the general formula Ib
- R 1 has the meaning given above
- R 3 represents an alkyl group with a maximum of 4 carbon atoms.
- the 17-oxosteroids formed from these compounds can be used, for example, to prepare the pharmacologically active 17 ⁇ -ethynyl-17 ⁇ -hydroxy-4-estren-3-one or its 18-methyl homologue.
- R 1 has the meaning given above
- R 4 represents a hydrogen atom or a methyl group
- R 5 and R 6 together symbolize a lower alkyl dioxy group
- R 5 represents a hydrogen atom
- R 6 represents a lower alkoxy group, a lower 1-alkoxyalkoxy group or a 2-tetrahydropyranyl group.
- the 17-oxosteroids obtained from these compounds can be processed further in the same way as those from the estran-17 ⁇ -ol derivatives of the general formula Ic; on the other hand, they can also be used to produce Pregnan derivatives, as is well known to the person skilled in the art, Finally, mention should also be made of estra n-7ß-ol derivatives of the general formula Id
- R 1 has the meaning given above
- R 9 symbolizes a hydrogen atom and R 7 and R 8 together symbolize a lower alkylenedioxy group or
- R 7 and R 9 represent two hydrogen atoms or together a carbon-carbon bond
- R 8 represents a lower alkoxy group, a lower 1-alkoxyalkoxy group or a 2-tetrahydropyranyloxy group.
- ketones obtained from these compounds can be converted into anti-gestagenic steroids by the process as described in EP-A 0129499.
- Example 1 A 500 ml Erlenmeyer with 100 ml sterile nutrient medium containing 1% yeast extract
- Tween 80 with a pH of 6.7 is with a suspension of a Mycobacterium spec. Inoculated NRRL B-3683 culture and shaken for 72 hours at 30 ° C at 180 revolutions per minute. b) 50 Erlenmeyer (100 ml) containing 20 ml of sterile culture medium each
- Example 2 a) The cultivation culture is prepared as indicated in Example 1a). b) 50 Erlenmeyer (100 ml) each containing 20 ml of sterile nutrient medium
- each culture is placed in 0.002 g of sterile-filtered ⁇ -equilol dissolved in 0.2 ml of dimethylformamide and fermented for a further 72 hours at 30 ° C. c)
- the product is isolated as described under 1c).
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Record Information Processing For Printing (AREA)
- Auxiliary Devices For And Details Of Packaging Control (AREA)
- Oscillators With Electromechanical Resonators (AREA)
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU82284/91A AU650467B2 (en) | 1990-08-18 | 1991-08-01 | Method of preparing 17-oxosteroids |
EP91913348A EP0496846B1 (de) | 1990-08-18 | 1991-08-01 | Verfahren zur herstellung von 17-oxosteroiden |
DE59108700T DE59108700D1 (de) | 1990-08-18 | 1991-08-01 | Verfahren zur herstellung von 17-oxosteroiden |
CA002069956A CA2069956C (en) | 1990-08-18 | 1991-08-01 | Process for the production of 17-oxosteroids |
SU915011897A RU2082762C1 (ru) | 1990-08-18 | 1991-08-01 | Способ получения 17-оксостероидов |
FI921697A FI102973B1 (fi) | 1990-08-18 | 1992-04-15 | Menetelmä 17-oksosteroidien valmistamiseksi |
GR970401833T GR3024188T3 (en) | 1990-08-18 | 1997-07-22 | Method of preparing 17-oxosteroids |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4026462 | 1990-08-18 | ||
DEP4026462.9 | 1990-08-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1992003572A1 true WO1992003572A1 (de) | 1992-03-05 |
Family
ID=6412643
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE1991/000628 WO1992003572A1 (de) | 1990-08-18 | 1991-08-01 | Verfahren zur herstellung von 17-oxosteroiden |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0496846B1 (de) |
JP (1) | JP3137645B2 (de) |
AT (1) | ATE152773T1 (de) |
AU (1) | AU650467B2 (de) |
CA (1) | CA2069956C (de) |
CZ (1) | CZ279575B6 (de) |
DE (1) | DE59108700D1 (de) |
DK (1) | DK0496846T3 (de) |
ES (1) | ES2103818T3 (de) |
FI (1) | FI102973B1 (de) |
GR (1) | GR3024188T3 (de) |
HU (1) | HU213017B (de) |
RU (1) | RU2082762C1 (de) |
SK (1) | SK279666B6 (de) |
WO (1) | WO1992003572A1 (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6593321B2 (en) * | 2001-06-11 | 2003-07-15 | Southwest Foundation For Biomedical Research | 2-alkoxyestradiol analogs with antiproliferative and antimitotic activity |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7335650B2 (en) | 2000-01-14 | 2008-02-26 | Sterix Limited | Composition |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0129499A2 (de) * | 1983-06-15 | 1984-12-27 | Schering Aktiengesellschaft | 13alpha-Alkylgonane, deren Herstellung und diese enthaltende pharmazeutische Präparate |
EP0322081A1 (de) * | 1987-12-23 | 1989-06-28 | Roussel-Uclaf | Mikrobiologische Herstellung von 9-Alpha-hydroxy-17-keto-steroiden |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3386890A (en) * | 1965-07-12 | 1968-06-04 | American Home Prod | Process for preparing equilin |
-
1991
- 1991-08-01 AU AU82284/91A patent/AU650467B2/en not_active Ceased
- 1991-08-01 CA CA002069956A patent/CA2069956C/en not_active Expired - Fee Related
- 1991-08-01 AT AT91913348T patent/ATE152773T1/de not_active IP Right Cessation
- 1991-08-01 HU HU9201646A patent/HU213017B/hu not_active IP Right Cessation
- 1991-08-01 WO PCT/DE1991/000628 patent/WO1992003572A1/de active IP Right Grant
- 1991-08-01 ES ES91913348T patent/ES2103818T3/es not_active Expired - Lifetime
- 1991-08-01 JP JP03512503A patent/JP3137645B2/ja not_active Expired - Fee Related
- 1991-08-01 DK DK91913348.8T patent/DK0496846T3/da active
- 1991-08-01 EP EP91913348A patent/EP0496846B1/de not_active Expired - Lifetime
- 1991-08-01 DE DE59108700T patent/DE59108700D1/de not_active Expired - Lifetime
- 1991-08-01 RU SU915011897A patent/RU2082762C1/ru not_active IP Right Cessation
- 1991-08-16 CZ CS912549A patent/CZ279575B6/cs not_active IP Right Cessation
- 1991-08-16 SK SK2549-91A patent/SK279666B6/sk unknown
-
1992
- 1992-04-15 FI FI921697A patent/FI102973B1/fi not_active IP Right Cessation
-
1997
- 1997-07-22 GR GR970401833T patent/GR3024188T3/el unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0129499A2 (de) * | 1983-06-15 | 1984-12-27 | Schering Aktiengesellschaft | 13alpha-Alkylgonane, deren Herstellung und diese enthaltende pharmazeutische Präparate |
EP0322081A1 (de) * | 1987-12-23 | 1989-06-28 | Roussel-Uclaf | Mikrobiologische Herstellung von 9-Alpha-hydroxy-17-keto-steroiden |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6593321B2 (en) * | 2001-06-11 | 2003-07-15 | Southwest Foundation For Biomedical Research | 2-alkoxyestradiol analogs with antiproliferative and antimitotic activity |
Also Published As
Publication number | Publication date |
---|---|
JP3137645B2 (ja) | 2001-02-26 |
DE59108700D1 (de) | 1997-06-12 |
ES2103818T3 (es) | 1997-10-01 |
FI102973B (fi) | 1999-03-31 |
GR3024188T3 (en) | 1997-10-31 |
AU650467B2 (en) | 1994-06-23 |
FI921697A0 (fi) | 1992-04-15 |
DK0496846T3 (da) | 1997-12-01 |
CS254991A3 (en) | 1992-02-19 |
HU213017B (en) | 1997-01-28 |
EP0496846B1 (de) | 1997-05-07 |
ATE152773T1 (de) | 1997-05-15 |
HU9201646D0 (en) | 1992-08-28 |
HUT64603A (en) | 1994-01-28 |
FI102973B1 (fi) | 1999-03-31 |
SK279666B6 (sk) | 1999-02-11 |
CA2069956C (en) | 2001-05-08 |
CZ279575B6 (cs) | 1995-05-17 |
JPH05503218A (ja) | 1993-06-03 |
RU2082762C1 (ru) | 1997-06-27 |
AU8228491A (en) | 1992-03-17 |
CA2069956A1 (en) | 1992-02-19 |
EP0496846A1 (de) | 1992-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3876769T2 (de) | Mikrobiologische herstellung von 9-alpha-hydroxy-17-keto-steroiden. | |
EP0225892B1 (de) | Verfahren zur herstellung von 4-androsten-3,17-dion und 1,4-androstadien-3,17-dion | |
EP0054810B1 (de) | Verfahren zur Herstellung von 3-Oxo-delta-1,4-steroiden | |
EP0496846B1 (de) | Verfahren zur herstellung von 17-oxosteroiden | |
EP0496845B1 (de) | Verfahren zur herstellung von 4-pregnen-3,20-dion und seinen derivaten | |
EP0027829B1 (de) | Verfahren zur Herstellung von 9-Alpha-hydroxy-4-androsten-3,17-dion | |
EP0505514B1 (de) | VERFAHREN ZUR HERSTELLUNG VON $g(b)-CARBOLIN-DERIVATEN | |
US5472854A (en) | Process for the production of 17-oxosteroids via the fermentative oxidation of 17β-hydroxysteroids by Mycobacterium | |
EP0227588B1 (de) | Verfahren zur Herstellung von 4-Androsten-3, 17-dion und 1,4-Androstadien-3,17-dion | |
DD139859A5 (de) | Verfahren zur herstellung von 21-hydroxy-20-methylpregnanen | |
EP0114984B1 (de) | Verfahren zur Herstellung von 3,11-alpha-Dihydroxy-1,3,5(10)-östratrien-Derivaten | |
WO1987005940A1 (en) | PROCESS FOR THE PRODUCTION OF 17aalpha-HYDROXY-D-HOMO-1,4-PREGNADIENE-3,20-DION | |
EP0019162B1 (de) | 12-alpha-Hydroxysteroide und deren Herstellung | |
EP0496854B1 (de) | Verfahren zur Herstellung von 20-METHYL-5,7-PREGNADIEN-3$g(b),21-DIOL-DERIVATIVEN | |
DE2803661A1 (de) | Neue in 17-position substituierte 11beta-hydroxysteroide der pregnanreihe, ihre herstellung und verwendung | |
DE2558089A1 (de) | Verfahren zur herstellung von androstan-3,17-dion-derivaten | |
EP0028309A1 (de) | Verfahren zur Herstellung von 11-alpha-Hydroxy-20-alpha-hydroxymethyl-1,4-pregnadien-3-on | |
DE2901563A1 (de) | 17 alpha -acyloxy-12 beta -hydroxy-4pregnen-3,20-dion-derivate und verfahren zu ihrer herstellung | |
DE2203535A1 (de) | Verfahren zur herstellung von 6-ketosteroiden | |
DE2850047A1 (de) | Verfahren zur herstellung von 9 alpha -hydroxy-4-androsten-3,17-dion | |
DD151947A5 (de) | Verfahren zur herstellung von 11 beta-hydroxysteroiden |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA FI HU JP SU US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1991913348 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 921697 Country of ref document: FI |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2069956 Country of ref document: CA |
|
WWP | Wipo information: published in national office |
Ref document number: 1991913348 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1991913348 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 921697 Country of ref document: FI |